These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 1310159

  • 21. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
    Rivera E, Ajani JA.
    Am J Clin Oncol; 1998 Feb; 21(1):36-8. PubMed ID: 9499254
    [Abstract] [Full Text] [Related]

  • 22. Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.
    Kraybill WG, Anderson DD, Lindell TD, Fletcher WS.
    Am Surg; 1976 Jul; 42(7):467-70. PubMed ID: 180857
    [No Abstract] [Full Text] [Related]

  • 23. Phase I trial of chlorozotocin.
    Gralla RJ, Tan CT, Young CW.
    Cancer Treat Rep; 1979 Jan; 63(1):17-20. PubMed ID: 154363
    [Abstract] [Full Text] [Related]

  • 24. [Chemotherapy for advanced pancreatic carcinoma].
    Yokoyama T, Shimada Y.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
    [Abstract] [Full Text] [Related]

  • 25. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA, Moertel CG, Fleming TR, Rubin JR, Krook JE, Everson LK, Windschitl HE, Twito DI, Marschke RF, Foley JF.
    JAMA; 1985 Apr 12; 253(14):2061-7. PubMed ID: 2579257
    [Abstract] [Full Text] [Related]

  • 26. A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.
    Kulke MH, Wu B, Clark JW, Enzinger PC, Lynch TJ, Vincitore M, Michelini A, Fuchs CS.
    Cancer Invest; 2006 Apr 12; 24(3):229-34. PubMed ID: 16809148
    [Abstract] [Full Text] [Related]

  • 27. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
    Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, Stanisic TH, Smith JA, Sullivan J, Sarosdy MF.
    N Engl J Med; 1991 Oct 24; 325(17):1205-9. PubMed ID: 1922207
    [Abstract] [Full Text] [Related]

  • 28. The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
    Delaunoit T, Ducreux M, Boige V, Dromain C, Sabourin JC, Duvillard P, Schlumberger M, de Baere T, Rougier P, Ruffie P, Elias D, Lasser P, Baudin E.
    Eur J Cancer; 2004 Mar 24; 40(4):515-20. PubMed ID: 14962717
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancer.
    Gisselbrecht C, Smith FP, MacDonald JS, Korsmeyer SJ, Boiron M, Woolley PV, Schein PS.
    Cancer; 1983 May 15; 51(10):1792-4. PubMed ID: 6219735
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
    Engstrom PF, Lavin PT, Moertel CG, Folsch E, Douglass HO.
    J Clin Oncol; 1984 Nov 15; 2(11):1255-9. PubMed ID: 6238136
    [Abstract] [Full Text] [Related]

  • 37. 5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230.
    Awrich A, Fletcher WS, Klotz JH, Minton JP, Hill GJ, Aust JB, Grage TB, Multhauf PM.
    J Surg Oncol; 1979 Nov 15; 12(3):267-73. PubMed ID: 228123
    [Abstract] [Full Text] [Related]

  • 38. Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma.
    Karatas F, Sahin S, Aytekin A, Hacioglu MB, Imamoglu GI, Altinbas M.
    J Cancer Res Ther; 2018 Nov 15; 14(5):1149-1151. PubMed ID: 30197367
    [Abstract] [Full Text] [Related]

  • 39. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW, Gray R, Panasci L, Perry MC.
    Cancer; 1986 Jan 01; 57(1):29-33. PubMed ID: 2934124
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.